Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

'It is a journey of discovery': living with myeloma.

de Wet R, Lane H, Tandon A, Augustson B, Joske D.

Support Care Cancer. 2018 Oct 27. doi: 10.1007/s00520-018-4502-9. [Epub ahead of print]

PMID:
30368672
2.

Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.

Trotman J, Cheah CY, Marlton P, Opat S.

Intern Med J. 2018 Sep 19. doi: 10.1111/imj.14113. [Epub ahead of print] Review.

PMID:
30230156
3.

FDG-PET/CT in the management of lymphomas: current status and future directions.

El-Galaly TC, Villa D, Gormsen LC, Baech J, Lo A, Cheah CY.

J Intern Med. 2018 Oct;284(4):358-376. doi: 10.1111/joim.12813. Epub 2018 Jul 24. Review.

PMID:
29989234
4.

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis.

Chihara D, Fowler NH, Oki Y, Fanale MA, Nastoupil LJ, Westin JR, Fayad LE, Neelapu SS, Cheah CY.

Oncotarget. 2018 Jun 22;9(48):28897-28902. doi: 10.18632/oncotarget.25622. eCollection 2018 Jun 22.

5.

Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement.

Chihara D, Oki Y, Fanale MA, Westin JR, Nastoupil LJ, Neelapu S, Fayad L, Fowler NH, Cheah CY.

Br J Haematol. 2018 Jul 5. doi: 10.1111/bjh.15444. [Epub ahead of print] No abstract available.

PMID:
29978452
6.

Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement.

Chin CK, Tsang E, Mediwake H, Khair W, Biccler J, Hapgood G, Mollee P, Nizich Z, Joske D, Radeski D, Cull G, Villa D, El-Galaly TC, Cheah CY.

Br J Haematol. 2018 Apr 20. doi: 10.1111/bjh.15173. [Epub ahead of print] No abstract available.

PMID:
29676487
7.

First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL.

Byrd JC, Smith S, Wagner-Johnston N, Sharman J, Chen AI, Advani R, Augustson B, Marlton P, Renee Commerford S, Okrah K, Liu L, Murray E, Penuel E, Ward AF, Flinn IW.

Oncotarget. 2018 Jan 22;9(16):13023-13035. doi: 10.18632/oncotarget.24310. eCollection 2018 Feb 27.

8.

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.

El-Galaly TC, Cheah CY, Bendtsen MD, Nowakowski GS, Kansara R, Savage KJ, Connors JM, Sehn LH, Goldschmidt N, Shaulov A, Farooq U, Link BK, Ferreri AJM, Calimeri T, Cecchetti C, Dann EJ, Thompson CA, Inbar T, Maurer MJ, Gade IL, Juul MB, Hansen JW, Holmberg S, Larsen TS, Cordua S, Mikhaeel NG, Hutchings M, Seymour JF, Clausen MR, Smith D, Opat S, Gilbertson M, Thanarajasingam G, Villa D.

Eur J Cancer. 2018 Apr;93:57-68. doi: 10.1016/j.ejca.2018.01.073. Epub 2018 Feb 21.

PMID:
29477102
9.

Novel agents for relapsed and refractory follicular lymphoma.

Cheah CY, Fowler NH.

Best Pract Res Clin Haematol. 2018 Mar;31(1):41-48. doi: 10.1016/j.beha.2017.11.003. Epub 2017 Nov 16. Review.

PMID:
29452665
10.

Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma.

Quach H, Benson S, Haysom H, Wilkes AM, Zacher N, Cole-Sinclair M, Miles Prince H, Mollee P, Spencer A, Joy Ho P, Harrison SJ, Lee C, Augustson B, Daly J.

Intern Med J. 2018 Feb;48(2):210-220. doi: 10.1111/imj.13707. Review.

PMID:
29415351
11.

The Diagnostic, Prognostic, and Therapeutic Utility of Molecular Testing in a Patient with Waldenstrom's Macroglobulinemia.

Chin CK, Leslie C, Grove CS, Van Vliet C, Cheah CY.

Int J Mol Sci. 2017 Sep 22;18(10). pii: E2038. doi: 10.3390/ijms18102038.

12.

Questioning the value of routine imaging for patients with mantle cell lymphoma in first remission.

El-Galaly TC, Cheah CY.

Leuk Lymphoma. 2018 Apr;59(4):775-777. doi: 10.1080/10428194.2017.1365863. Epub 2017 Aug 22. No abstract available.

PMID:
28828884
13.

Bisphosphonate guidelines for treatment and prevention of myeloma bone disease.

Lee OL, Horvath N, Lee C, Joshua D, Ho J, Szer J, Quach H, Spencer A, Harrison S, Mollee P, Roberts AW, Talaulikar D, Brown R, Augustson B, Ling S, Jaksic W, Gibson J, Kalff A, Johnston A, Kalro A, Ward C, Prince HM, Zannettino A.

Intern Med J. 2017 Aug;47(8):938-951. doi: 10.1111/imj.13502.

PMID:
28782211
14.

How I treat patients with aggressive lymphoma at high risk of CNS relapse.

Chin CK, Cheah CY.

Blood. 2017 Aug 17;130(7):867-874. doi: 10.1182/blood-2017-03-737460. Epub 2017 Jun 13. Review.

15.

A mutation in PTPN11 may drive leukemic transformation in a case of essential thrombocythemia.

Guo BB, Liang J, Allcock RJN, Mirzai B, Augustson B, Howman R, Fuller KA, Erber WN.

Leuk Lymphoma. 2018 Jan;59(1):245-248. doi: 10.1080/10428194.2017.1324162. Epub 2017 Jun 7. No abstract available.

PMID:
28587547
16.

Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma.

Fanale MA, Cheah CY, Rich A, Medeiros LJ, Lai CM, Oki Y, Romaguera JE, Fayad LE, Hagemeister FB, Samaniego F, Rodriguez MA, Neelapu SS, Lee HJ, Nastoupil L, Fowler NH, Turturro F, Westin JR, Wang ML, McLaughlin P, Pinnix CC, Milgrom SA, Dabaja B, Horowitz SB, Younes A.

Blood. 2017 Jul 27;130(4):472-477. doi: 10.1182/blood-2017-02-766121. Epub 2017 May 18.

17.

Three different hematologists, three different answers: how should we treat concurrent systemic and central nervous system lymphoma?

Barraclough AA, Cheah CY.

Leuk Lymphoma. 2017 Sep;58(9):1-3. doi: 10.1080/10428194.2017.1307364. Epub 2017 Apr 3. No abstract available.

PMID:
28367720
18.

The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy.

El-Galaly TC, Villa D, Michaelsen TY, Hutchings M, Mikhaeel NG, Savage KJ, Sehn LH, Barrington S, Hansen JW, Smith D, Rady K, Mylam KJ, Larsen TS, Holmberg S, Juul MB, Cordua S, Clausen MR, Jensen KB, Johnsen HE, Seymour JF, Connors JM, de Nully Brown P, Bøgsted M, Cheah CY.

Eur J Cancer. 2017 Apr;75:195-203. doi: 10.1016/j.ejca.2016.12.029. Epub 2017 Feb 23.

PMID:
28237865
19.

When to treat patients with relapsed follicular lymphoma.

Cheah CY, Seymour JF.

Expert Rev Hematol. 2017 Mar;10(3):187-191. doi: 10.1080/17474086.2017.1291339. Epub 2017 Feb 15. Review.

PMID:
28164722
20.

Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

Talaulikar D, Tam CS, Joshua D, Ho JP, Szer J, Quach H, Spencer A, Harrison S, Mollee P, Roberts AW, Horvath N, Lee C, Zannettino A, Brown R, Augustson B, Jaksic W, Gibson J, Kalff A, Johnston A, Trotman J, Kalro A, Grigoriadis G, Ward C, Prince HM.

Intern Med J. 2017 Jan;47(1):35-49. doi: 10.1111/imj.13311.

PMID:
28076910

Supplemental Content

Loading ...
Support Center